跳至主要内容
临床试验/SLCTR/2024/003
SLCTR/2024/003尚未招募Unknown

Heart Failure with Reduced Ejection Fraction Polypill Implementation Strategy in South Asia: A Pilot Randomized Trial

Washington University in St. Louis0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Adults [>=18 years old)
  • 2.Diagnosis of heart failure with reduced ejection fraction (HFrEF) including clinical symptoms or clinical signs or natriuretic peptide elevation AND echocardiographic or other evidence of reduced ejection fraction (EF=<40%)
  • 3.New York Heart Association Class II, III, or IV symptoms

排除标准

  • 1.Known contraindication to any of the HFrEF polypill components (e.g., advanced renal
  • disease, bradycardia, allergy, amongst others).
  • 2.Significant renal impairment (estimated glomerular filtration rate <30 mL/min/1.73 m
  • 3.Raised serum potassium >5 mEq/L.
  • 4.Symptomatic hypotension or systolic BP <100 mmHg as per the average of last 2 of the measurements at visit 1.
  • 5.Symptomatic bradycardia or second or third-degree heart block without a pacemaker on ECG review at visit 1.
  • 6.Myocardial infarction, unstable angina, stroke or transient ischemic attack (TIA) within 12 weeks prior to enrollment.
  • 7.Women who are pregnant, breastfeeding or of childbearing potential and are not using and do not plan to continue using medically acceptable form of contraception throughout the study (pharmacological or barrier methods).
  • 8.Concomitant illness, physical impairment or mental condition which in the opinion of the study team / primary physician could interfere with the conduct of the study including outcome assessment.
  • 9.Participation in a concurrent interventional medical investigation or pharmacologic clinical trial. Patients in observational, natural history or epidemiological studies not involving an intervention are eligible.
  • 10.Participant’s responsible physician believes it is not appropriate for participant to participate in the study.
  • 11.Inability or unwillingness to provide written informed consent.
  • 12.Involvement in the planning and/or conduct of the study.
  • 13.Unable to complete study procedures and/or plan to move out of the study site area in the next 2 months.

研究者

相似试验